The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Epigenetics Diagnostic Market Research Report 2024
Synopsis
The relative specificity of many epigenetic changes for neoplastic cells has allowed the identification of diagnostic, prognostic and predictive biomarkers for a number of solid tumors and hematological malignancies.
The global Epigenetics Diagnostic market was valued at US$ 5197.9 million in 2023 and is anticipated to reach US$ 14450 million by 2030, witnessing a CAGR of 15.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Epigenetics Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Epigenetics Diagnostic.
Report Scope
The Epigenetics Diagnostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Epigenetics Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Epigenetics Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche Diagnostics
Thermo Fisher Scientific, Inc.
Eisai Co. Ltd.
Novartis AG
Illumina, Inc.
Merck
Qiagen
Abcam plc
Diagenode Diagnostics
Active Motif
Zymo Research Corporation
CellCentric
Valirx
Segment by Type
Reagents
Kits
Instruments
Enzymes
Services
Segment by Application
Oncolog
Non-oncology
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Epigenetics Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The relative specificity of many epigenetic changes for neoplastic cells has allowed the identification of diagnostic, prognostic and predictive biomarkers for a number of solid tumors and hematological malignancies.
The global Epigenetics Diagnostic market was valued at US$ 5197.9 million in 2023 and is anticipated to reach US$ 14450 million by 2030, witnessing a CAGR of 15.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Epigenetics Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Epigenetics Diagnostic.
Report Scope
The Epigenetics Diagnostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Epigenetics Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Epigenetics Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche Diagnostics
Thermo Fisher Scientific, Inc.
Eisai Co. Ltd.
Novartis AG
Illumina, Inc.
Merck
Qiagen
Abcam plc
Diagenode Diagnostics
Active Motif
Zymo Research Corporation
CellCentric
Valirx
Segment by Type
Reagents
Kits
Instruments
Enzymes
Services
Segment by Application
Oncolog
Non-oncology
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Epigenetics Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Epigenetics Diagnostic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Reagents
1.2.3 Kits
1.2.4 Instruments
1.2.5 Enzymes
1.2.6 Services
1.3 Market by Application
1.3.1 Global Epigenetics Diagnostic Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Oncolog
1.3.3 Non-oncology
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Epigenetics Diagnostic Market Perspective (2019-2030)
2.2 Epigenetics Diagnostic Growth Trends by Region
2.2.1 Global Epigenetics Diagnostic Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Epigenetics Diagnostic Historic Market Size by Region (2019-2024)
2.2.3 Epigenetics Diagnostic Forecasted Market Size by Region (2025-2030)
2.3 Epigenetics Diagnostic Market Dynamics
2.3.1 Epigenetics Diagnostic Industry Trends
2.3.2 Epigenetics Diagnostic Market Drivers
2.3.3 Epigenetics Diagnostic Market Challenges
2.3.4 Epigenetics Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Epigenetics Diagnostic Players by Revenue
3.1.1 Global Top Epigenetics Diagnostic Players by Revenue (2019-2024)
3.1.2 Global Epigenetics Diagnostic Revenue Market Share by Players (2019-2024)
3.2 Global Epigenetics Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Epigenetics Diagnostic Revenue
3.4 Global Epigenetics Diagnostic Market Concentration Ratio
3.4.1 Global Epigenetics Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Epigenetics Diagnostic Revenue in 2023
3.5 Epigenetics Diagnostic Key Players Head office and Area Served
3.6 Key Players Epigenetics Diagnostic Product Solution and Service
3.7 Date of Enter into Epigenetics Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Epigenetics Diagnostic Breakdown Data by Type
4.1 Global Epigenetics Diagnostic Historic Market Size by Type (2019-2024)
4.2 Global Epigenetics Diagnostic Forecasted Market Size by Type (2025-2030)
5 Epigenetics Diagnostic Breakdown Data by Application
5.1 Global Epigenetics Diagnostic Historic Market Size by Application (2019-2024)
5.2 Global Epigenetics Diagnostic Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Epigenetics Diagnostic Market Size (2019-2030)
6.2 North America Epigenetics Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Epigenetics Diagnostic Market Size by Country (2019-2024)
6.4 North America Epigenetics Diagnostic Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Epigenetics Diagnostic Market Size (2019-2030)
7.2 Europe Epigenetics Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Epigenetics Diagnostic Market Size by Country (2019-2024)
7.4 Europe Epigenetics Diagnostic Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Epigenetics Diagnostic Market Size (2019-2030)
8.2 Asia-Pacific Epigenetics Diagnostic Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Epigenetics Diagnostic Market Size by Region (2019-2024)
8.4 Asia-Pacific Epigenetics Diagnostic Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Epigenetics Diagnostic Market Size (2019-2030)
9.2 Latin America Epigenetics Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Epigenetics Diagnostic Market Size by Country (2019-2024)
9.4 Latin America Epigenetics Diagnostic Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Epigenetics Diagnostic Market Size (2019-2030)
10.2 Middle East & Africa Epigenetics Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Epigenetics Diagnostic Market Size by Country (2019-2024)
10.4 Middle East & Africa Epigenetics Diagnostic Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Detail
11.1.2 Roche Diagnostics Business Overview
11.1.3 Roche Diagnostics Epigenetics Diagnostic Introduction
11.1.4 Roche Diagnostics Revenue in Epigenetics Diagnostic Business (2019-2024)
11.1.5 Roche Diagnostics Recent Development
11.2 Thermo Fisher Scientific, Inc.
11.2.1 Thermo Fisher Scientific, Inc. Company Detail
11.2.2 Thermo Fisher Scientific, Inc. Business Overview
11.2.3 Thermo Fisher Scientific, Inc. Epigenetics Diagnostic Introduction
11.2.4 Thermo Fisher Scientific, Inc. Revenue in Epigenetics Diagnostic Business (2019-2024)
11.2.5 Thermo Fisher Scientific, Inc. Recent Development
11.3 Eisai Co. Ltd.
11.3.1 Eisai Co. Ltd. Company Detail
11.3.2 Eisai Co. Ltd. Business Overview
11.3.3 Eisai Co. Ltd. Epigenetics Diagnostic Introduction
11.3.4 Eisai Co. Ltd. Revenue in Epigenetics Diagnostic Business (2019-2024)
11.3.5 Eisai Co. Ltd. Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Detail
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Epigenetics Diagnostic Introduction
11.4.4 Novartis AG Revenue in Epigenetics Diagnostic Business (2019-2024)
11.4.5 Novartis AG Recent Development
11.5 Illumina, Inc.
11.5.1 Illumina, Inc. Company Detail
11.5.2 Illumina, Inc. Business Overview
11.5.3 Illumina, Inc. Epigenetics Diagnostic Introduction
11.5.4 Illumina, Inc. Revenue in Epigenetics Diagnostic Business (2019-2024)
11.5.5 Illumina, Inc. Recent Development
11.6 Merck
11.6.1 Merck Company Detail
11.6.2 Merck Business Overview
11.6.3 Merck Epigenetics Diagnostic Introduction
11.6.4 Merck Revenue in Epigenetics Diagnostic Business (2019-2024)
11.6.5 Merck Recent Development
11.7 Qiagen
11.7.1 Qiagen Company Detail
11.7.2 Qiagen Business Overview
11.7.3 Qiagen Epigenetics Diagnostic Introduction
11.7.4 Qiagen Revenue in Epigenetics Diagnostic Business (2019-2024)
11.7.5 Qiagen Recent Development
11.8 Abcam plc
11.8.1 Abcam plc Company Detail
11.8.2 Abcam plc Business Overview
11.8.3 Abcam plc Epigenetics Diagnostic Introduction
11.8.4 Abcam plc Revenue in Epigenetics Diagnostic Business (2019-2024)
11.8.5 Abcam plc Recent Development
11.9 Diagenode Diagnostics
11.9.1 Diagenode Diagnostics Company Detail
11.9.2 Diagenode Diagnostics Business Overview
11.9.3 Diagenode Diagnostics Epigenetics Diagnostic Introduction
11.9.4 Diagenode Diagnostics Revenue in Epigenetics Diagnostic Business (2019-2024)
11.9.5 Diagenode Diagnostics Recent Development
11.10 Active Motif
11.10.1 Active Motif Company Detail
11.10.2 Active Motif Business Overview
11.10.3 Active Motif Epigenetics Diagnostic Introduction
11.10.4 Active Motif Revenue in Epigenetics Diagnostic Business (2019-2024)
11.10.5 Active Motif Recent Development
11.11 Zymo Research Corporation
11.11.1 Zymo Research Corporation Company Detail
11.11.2 Zymo Research Corporation Business Overview
11.11.3 Zymo Research Corporation Epigenetics Diagnostic Introduction
11.11.4 Zymo Research Corporation Revenue in Epigenetics Diagnostic Business (2019-2024)
11.11.5 Zymo Research Corporation Recent Development
11.12 CellCentric
11.12.1 CellCentric Company Detail
11.12.2 CellCentric Business Overview
11.12.3 CellCentric Epigenetics Diagnostic Introduction
11.12.4 CellCentric Revenue in Epigenetics Diagnostic Business (2019-2024)
11.12.5 CellCentric Recent Development
11.13 Valirx
11.13.1 Valirx Company Detail
11.13.2 Valirx Business Overview
11.13.3 Valirx Epigenetics Diagnostic Introduction
11.13.4 Valirx Revenue in Epigenetics Diagnostic Business (2019-2024)
11.13.5 Valirx Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Epigenetics Diagnostic Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Reagents
Table 3. Key Players of Kits
Table 4. Key Players of Instruments
Table 5. Key Players of Enzymes
Table 6. Key Players of Services
Table 7. Global Epigenetics Diagnostic Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Epigenetics Diagnostic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Epigenetics Diagnostic Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Epigenetics Diagnostic Market Share by Region (2019-2024)
Table 11. Global Epigenetics Diagnostic Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Epigenetics Diagnostic Market Share by Region (2025-2030)
Table 13. Epigenetics Diagnostic Market Trends
Table 14. Epigenetics Diagnostic Market Drivers
Table 15. Epigenetics Diagnostic Market Challenges
Table 16. Epigenetics Diagnostic Market Restraints
Table 17. Global Epigenetics Diagnostic Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Epigenetics Diagnostic Market Share by Players (2019-2024)
Table 19. Global Top Epigenetics Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epigenetics Diagnostic as of 2023)
Table 20. Ranking of Global Top Epigenetics Diagnostic Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Epigenetics Diagnostic Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Epigenetics Diagnostic Product Solution and Service
Table 24. Date of Enter into Epigenetics Diagnostic Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Epigenetics Diagnostic Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Epigenetics Diagnostic Revenue Market Share by Type (2019-2024)
Table 28. Global Epigenetics Diagnostic Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Epigenetics Diagnostic Revenue Market Share by Type (2025-2030)
Table 30. Global Epigenetics Diagnostic Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Epigenetics Diagnostic Revenue Market Share by Application (2019-2024)
Table 32. Global Epigenetics Diagnostic Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Epigenetics Diagnostic Revenue Market Share by Application (2025-2030)
Table 34. North America Epigenetics Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Epigenetics Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Epigenetics Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Epigenetics Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Epigenetics Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Epigenetics Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Epigenetics Diagnostic Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Epigenetics Diagnostic Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Epigenetics Diagnostic Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Epigenetics Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Epigenetics Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Epigenetics Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Epigenetics Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Epigenetics Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Epigenetics Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 49. Roche Diagnostics Company Detail
Table 50. Roche Diagnostics Business Overview
Table 51. Roche Diagnostics Epigenetics Diagnostic Product
Table 52. Roche Diagnostics Revenue in Epigenetics Diagnostic Business (2019-2024) & (US$ Million)
Table 53. Roche Diagnostics Recent Development
Table 54. Thermo Fisher Scientific, Inc. Company Detail
Table 55. Thermo Fisher Scientific, Inc. Business Overview
Table 56. Thermo Fisher Scientific, Inc. Epigenetics Diagnostic Product
Table 57. Thermo Fisher Scientific, Inc. Revenue in Epigenetics Diagnostic Business (2019-2024) & (US$ Million)
Table 58. Thermo Fisher Scientific, Inc. Recent Development
Table 59. Eisai Co. Ltd. Company Detail
Table 60. Eisai Co. Ltd. Business Overview
Table 61. Eisai Co. Ltd. Epigenetics Diagnostic Product
Table 62. Eisai Co. Ltd. Revenue in Epigenetics Diagnostic Business (2019-2024) & (US$ Million)
Table 63. Eisai Co. Ltd. Recent Development
Table 64. Novartis AG Company Detail
Table 65. Novartis AG Business Overview
Table 66. Novartis AG Epigenetics Diagnostic Product
Table 67. Novartis AG Revenue in Epigenetics Diagnostic Business (2019-2024) & (US$ Million)
Table 68. Novartis AG Recent Development
Table 69. Illumina, Inc. Company Detail
Table 70. Illumina, Inc. Business Overview
Table 71. Illumina, Inc. Epigenetics Diagnostic Product
Table 72. Illumina, Inc. Revenue in Epigenetics Diagnostic Business (2019-2024) & (US$ Million)
Table 73. Illumina, Inc. Recent Development
Table 74. Merck Company Detail
Table 75. Merck Business Overview
Table 76. Merck Epigenetics Diagnostic Product
Table 77. Merck Revenue in Epigenetics Diagnostic Business (2019-2024) & (US$ Million)
Table 78. Merck Recent Development
Table 79. Qiagen Company Detail
Table 80. Qiagen Business Overview
Table 81. Qiagen Epigenetics Diagnostic Product
Table 82. Qiagen Revenue in Epigenetics Diagnostic Business (2019-2024) & (US$ Million)
Table 83. Qiagen Recent Development
Table 84. Abcam plc Company Detail
Table 85. Abcam plc Business Overview
Table 86. Abcam plc Epigenetics Diagnostic Product
Table 87. Abcam plc Revenue in Epigenetics Diagnostic Business (2019-2024) & (US$ Million)
Table 88. Abcam plc Recent Development
Table 89. Diagenode Diagnostics Company Detail
Table 90. Diagenode Diagnostics Business Overview
Table 91. Diagenode Diagnostics Epigenetics Diagnostic Product
Table 92. Diagenode Diagnostics Revenue in Epigenetics Diagnostic Business (2019-2024) & (US$ Million)
Table 93. Diagenode Diagnostics Recent Development
Table 94. Active Motif Company Detail
Table 95. Active Motif Business Overview
Table 96. Active Motif Epigenetics Diagnostic Product
Table 97. Active Motif Revenue in Epigenetics Diagnostic Business (2019-2024) & (US$ Million)
Table 98. Active Motif Recent Development
Table 99. Zymo Research Corporation Company Detail
Table 100. Zymo Research Corporation Business Overview
Table 101. Zymo Research Corporation Epigenetics Diagnostic Product
Table 102. Zymo Research Corporation Revenue in Epigenetics Diagnostic Business (2019-2024) & (US$ Million)
Table 103. Zymo Research Corporation Recent Development
Table 104. CellCentric Company Detail
Table 105. CellCentric Business Overview
Table 106. CellCentric Epigenetics Diagnostic Product
Table 107. CellCentric Revenue in Epigenetics Diagnostic Business (2019-2024) & (US$ Million)
Table 108. CellCentric Recent Development
Table 109. Valirx Company Detail
Table 110. Valirx Business Overview
Table 111. Valirx Epigenetics Diagnostic Product
Table 112. Valirx Revenue in Epigenetics Diagnostic Business (2019-2024) & (US$ Million)
Table 113. Valirx Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Epigenetics Diagnostic Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Epigenetics Diagnostic Market Share by Type: 2023 VS 2030
Figure 3. Reagents Features
Figure 4. Kits Features
Figure 5. Instruments Features
Figure 6. Enzymes Features
Figure 7. Services Features
Figure 8. Global Epigenetics Diagnostic Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Epigenetics Diagnostic Market Share by Application: 2023 VS 2030
Figure 10. Oncolog Case Studies
Figure 11. Non-oncology Case Studies
Figure 12. Epigenetics Diagnostic Report Years Considered
Figure 13. Global Epigenetics Diagnostic Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Epigenetics Diagnostic Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Epigenetics Diagnostic Market Share by Region: 2023 VS 2030
Figure 16. Global Epigenetics Diagnostic Market Share by Players in 2023
Figure 17. Global Top Epigenetics Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epigenetics Diagnostic as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Epigenetics Diagnostic Revenue in 2023
Figure 19. North America Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Epigenetics Diagnostic Market Share by Country (2019-2030)
Figure 21. United States Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Epigenetics Diagnostic Market Share by Country (2019-2030)
Figure 25. Germany Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Epigenetics Diagnostic Market Share by Region (2019-2030)
Figure 33. China Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Epigenetics Diagnostic Market Share by Country (2019-2030)
Figure 41. Mexico Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Epigenetics Diagnostic Market Share by Country (2019-2030)
Figure 45. Turkey Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Epigenetics Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Roche Diagnostics Revenue Growth Rate in Epigenetics Diagnostic Business (2019-2024)
Figure 48. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Epigenetics Diagnostic Business (2019-2024)
Figure 49. Eisai Co. Ltd. Revenue Growth Rate in Epigenetics Diagnostic Business (2019-2024)
Figure 50. Novartis AG Revenue Growth Rate in Epigenetics Diagnostic Business (2019-2024)
Figure 51. Illumina, Inc. Revenue Growth Rate in Epigenetics Diagnostic Business (2019-2024)
Figure 52. Merck Revenue Growth Rate in Epigenetics Diagnostic Business (2019-2024)
Figure 53. Qiagen Revenue Growth Rate in Epigenetics Diagnostic Business (2019-2024)
Figure 54. Abcam plc Revenue Growth Rate in Epigenetics Diagnostic Business (2019-2024)
Figure 55. Diagenode Diagnostics Revenue Growth Rate in Epigenetics Diagnostic Business (2019-2024)
Figure 56. Active Motif Revenue Growth Rate in Epigenetics Diagnostic Business (2019-2024)
Figure 57. Zymo Research Corporation Revenue Growth Rate in Epigenetics Diagnostic Business (2019-2024)
Figure 58. CellCentric Revenue Growth Rate in Epigenetics Diagnostic Business (2019-2024)
Figure 59. Valirx Revenue Growth Rate in Epigenetics Diagnostic Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
